“Despite the clinical success of antiretroviral therapy (ART), more people contract human immunodeficiency virus (HIV) infection daily than initiate ART,” states the NIH RePORTER abstract for a new study receiving funding from the NIH. “The difficulties of lifelong ART - particularly in the developing world - make the eradication of HIV imperative. But clearance of a retroviral infection for patients on ART is a herculean task. While much is known about HIV persistence despite ART, many puzzles remain. New tools to address latent infection must replace the paradigms and models used to develop ART.”
A laboratory testing kit developed at the University of North Carolina Lineberger Comprehensive Cancer Center received approval from the U.S. Food and Drug Administration. Developed by Chuck Perou, PhD and professor of genetics and pathology, the testing kit estimates the risk of breast cancer relapse even in cases of anti-hormone treatment. According to the University of North Carolina at Chapel Hill, other scientists who worked with Perou include Dr. Joel Parker and Dr. Maggie Cheang at the University of North Carolina.
Four start-up medical companies at the University of North Carolina at Chapel Hill recently received $80,000 in life science funding the form of a federal grant. The donating organization, Carolina KickStart, is a program within the North Carolina Translational and Clinical Sciences Institute (NC TraCS). NC TraCS is funded by the NIH and works as a medical research center that awards grant money.
Tags: 2014, 2013, University of North Carolina at Chapel Hill, North Carolina, University of North Carolina, Southern, BioResearch Product Faire Event, NC, Front Line, Chapel Hill, UNC, life science research funding
In an article on our Science Market Update blog last week, we featured some life science funding news stories that we covered in our Life Science Company and Industry News Briefs blog the week before. We’d like to do the same this week because a number of last week’s funding news stories may be of interest to lab suppliers working to sell lab equipment at these well-funded research institutions. In the following paragraphs, we’ll give a brief summary of what schools received funding, how much funding they received, and what the topic of research is. We’ll also include links for further reading.
Tags: 2014, Emory University, Harvard University, Pennsylvania, Northeast, University of Pennsylvania, UPenn, University of North Carolina at Chapel Hill, Duke University, North Carolina, University of North Carolina, Life Science Funding, Southern, Georgia, Massachusetts, Boston, Philadelphia, Emory, BioResearch Product Faire Event, Durham, Harvard, Atlanta, Front Line, Chapel Hill, Duke, UNC
Researchers at the University of North Carolina at Chapel Hill recently made an important contribution to life science research with a study published in the September 13th, 2013 issue of the journal Science. Scientists have known for some time that there are sensors on the outside of cells that act as motion detectors for bacteria that may be dangerous. The researchers at the University of North Carolina at Chapel Hill found a sensor pathway inside of cells that that triggers a response by the immune system. According to the study, the interior sensors can work with the exterior sensors to detect a molecule called lipopolysaccharide, or LPS.
Tags: 2014, 2013, University of North Carolina at Chapel Hill, North Carolina, University of North Carolina, Southern, life science research, BioResearch Product Faire Event, NC, Chapel Hill, UNC, new study, new research
Researchers at Duke University and the University of North Carolina at Chapel Hill will both receive grant money to continue their breast cancer research. Ten programs at the two schools will receive $3.6 million from the Susan G. Komen Foundation, and the money will be used to study the causes of breast cancer and work towards developing vaccines.
The Bill & Melinda Gates Foundation recently gave the University of North Carolina at Chapel Hill $8 million to improve the health of mothers and infants in Malawi. UNC Project-Malawi was originally established to address the HIV/AIDS crisis in Malawi, and now works in improving the problems associated with malaria, pediatrics, trauma, burns, cancer, family planning, emergency obstetrics, tuberculosis and other infectious diseases. This story comes in the wake of a report that North Carolina triangle universities received $2 billion in funding last school year.
Tags: 2014, 2013, University of North Carolina at Chapel Hill, North Carolina, University of North Carolina, Southern, BioResearch Product Faire Event, Front Line event, NC, Front Line, Chapel Hill, UNC, UNC-Chapel Hill
Research scientists at the University of North Carolina School of Medicine, North Carolina State and Duke University recently conducted a study researching canine and human B-cell lymphoma by comparing the similarities and differences between the two species. The study is one of the first of its kind and was published on June 19, 2013 in the online journal Cancer Research.
A great deal of new biotech funding in North Carolina is calling national attention to the state's status as a life science research hub. Lab suppliers marketing life science solutions and university lab products will find high quality biotech sales leads at life science marketing events in North Carolina, given the state’s wealth of research funding available. The Republic recently reported that David Murdock, leader of Dole Food Company, Inc., is creating a permanent fund for a center known as the North Carolina Research Campus. The $50 million gift will be used for the campus’s health, agriculture and food research projects.